Life Technologies makes DNA sequencing more accessible to labs of all sizes

CARLSBAD, USA: Life Technologies Corp. announced a series of new product innovations across the company’s DNA sequencing portfolio.

To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies.

As a pioneer of DNA sequencing, Life Technologies continues to enable researchers in any size laboratory to access applications that meet their specific technical and financial research requirements. As a result of these innovations, researchers now have greater flexibility from their sequencing platforms, a more simplified sample preparation, increased data throughput and expedited data analysis.

“These advances underscore our commitment to bringing sequencing to the masses at a cost and scale that directly addresses the technical needs and financial hurdles facing the research community,” said Gregory T. Lucier, chairman and CEO of Life Technologies.

“By making DNA sequencing economically accessible to labs of all sizes, we are enabling novel research, not feasible using other technologies, in applied markets including synthetic biology, molecular medicine and food safety."